Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Myriad Genetics, Inc. - Common Stock (NQ:MYGN)

7.270 -0.430 (-5.58%)
Streaming Delayed Price Updated: 4:00 PM EDT, May 6, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,945,119
Open 7.650
Bid (Size) 6.010 (5)
Ask (Size) 6.160 (4)
Prev. Close 7.700
Today's Range 7.240 - 7.810
52wk Range 6.940 - 29.30
Shares Outstanding 91,300,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Myriad Genetics (NASDAQ:MYGN) Misses Q1 Sales Targets, Stock Drops 14.5%
Genetic testing company Myriad Genetics (NASDAQ:MYGN) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 3.1% year on year to $195.9 million. The company’s full-year revenue... 
Via StockStory
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga

Performance

YTD
-46.1%
-46.1%
1 Month
-9.9%
-9.9%
3 Month
-41.4%
-41.4%
6 Month
-58.7%
-58.7%
1 Year
-63.6%
-63.6%

More News

Read More
Myriad Genetics Reports First Quarter 2025 Financial Results; Updates 2025 Financial Guidance
From Myriad Genetics, Inc.
Via GlobeNewswire
Earnings Scheduled For May 6, 2025
Via Benzinga
Myriad Genetics's Earnings: A Preview
Via Benzinga
What To Expect From Myriad Genetics’s (MYGN) Q1 Earnings
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
3 Unprofitable Stocks Walking a Fine Line
Via StockStory
1 Unprofitable Stock to Target This Week and 2 to Be Wary Of
Via StockStory
Concerns about Mental Health Medication Side Effects Remain a Barrier to Getting Help for Those Diagnosed with Depression and Anxiety, According to the GeneSight Mental Health Monitor
From Myriad Genetics, Inc.
Via GlobeNewswire
Myriad Genetics to Release First Quarter 2025 Financial Results on May 6, 2025
From Myriad Genetics, Inc.
Via GlobeNewswire
Myriad Genetics Highlights MRD Clinical Validity Data at American Association for Cancer Research Annual Meeting
From Myriad Genetics, Inc.
Via GlobeNewswire
3 Healthcare Stocks That Concern Us
Via StockStory
Topics Stocks
Exposures COVID-19 US Equities
Myriad Genetics Announces Study Results Show Patients with Depression had Fewer Psychiatric Hospitalizations after GeneSight Testing
From Myriad Genetics, Inc.
Via GlobeNewswire
Demystifying Myriad Genetics: Insights From 10 Analyst Reviews
Via Benzinga
Myriad Genetics Announces Inducement Awards
From Myriad Genetics, Inc.
Via GlobeNewswire
Myriad Genetics Names Brian Donnelly as New Chief Commercial Officer
From Myriad Genetics, Inc.
Via GlobeNewswire
10 Analysts Assess Myriad Genetics: What You Need To Know
Via Benzinga
Excelerate Energy, MediaAlpha And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Via Benzinga
Why PVH Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
1 Small-Cap Stock on Our Watchlist and 2 to Avoid
Via StockStory
A Look Back at Therapeutics Stocks’ Q4 Earnings: Vertex Pharmaceuticals (NASDAQ:VRTX) Vs The Rest Of The Pack
Via StockStory
Topics Artificial Intelligence
Exposures Artificial Intelligence
Myriad Genetics (MYGN): Buy, Sell, or Hold Post Q4 Earnings?
Via StockStory
Analyst Sees Bottom For Myriad Genetics Stock, Issues Upgrade
Via Benzinga
Why Are Myriad Genetics (MYGN) Shares Soaring Today
Via StockStory
This HubSpot Analyst Turns Bullish; Here Are Top 5 Upgrades For Wednesday
Via Benzinga

Frequently Asked Questions

Is Myriad Genetics, Inc. - Common Stock publicly traded?
Yes, Myriad Genetics, Inc. - Common Stock is publicly traded.
What exchange does Myriad Genetics, Inc. - Common Stock trade on?
Myriad Genetics, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Myriad Genetics, Inc. - Common Stock?
The ticker symbol for Myriad Genetics, Inc. - Common Stock is MYGN on the Nasdaq Stock Market
What is the current price of Myriad Genetics, Inc. - Common Stock?
The current price of Myriad Genetics, Inc. - Common Stock is 7.270
When was Myriad Genetics, Inc. - Common Stock last traded?
The last trade of Myriad Genetics, Inc. - Common Stock was at 05/06/25 04:00 PM ET
What is the market capitalization of Myriad Genetics, Inc. - Common Stock?
The market capitalization of Myriad Genetics, Inc. - Common Stock is 663.75M
How many shares of Myriad Genetics, Inc. - Common Stock are outstanding?
Myriad Genetics, Inc. - Common Stock has 664M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.